JPMorgan Upgrades Replimune Group (REPL) to Neutral

June 1, 2026 1:06 AM

JPMorgan analyst Anupam Rama upgraded Replimune Group (NASDAQ: REPL) from Underweight to Neutral with a price target of $8.00.The analyst ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found